7.5K(top 4%)
articles
396.6K(top 2%)
citations
1,867(top 3%)
★★ articles
73(top 3%)
★★★ articles
2.1(top 30%)
Avg IF
244(top 2%)
H-Index
429(top 2%)
G-Index
1,365
journals

Most Cited Articles of GlaxoSmithKline in 2013

TitleJournalYearCitations
2012 revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis and Rheumatism20133.4K
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeArthritis and Rheumatism20131.6K
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophyScience2013837
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndromeScience2013755
The worldwide economic impact of dementia 2010Alzheimer's and Dementia2013641
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohortsPLoS Medicine2013592
Imaging structural co-variance between human brain regionsNature Reviews Neuroscience2013569
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformationCancer Cell2013547
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKLJournal of Biological Chemistry2013518
Evidence for a common mechanism of SIRT1 regulation by allosteric activatorsScience2013467
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseasesNature Reviews Neuroscience2013461
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architectureNature Genetics2013437
Drug discovery: a jump-start for electroceuticalsNature2013403
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic studyArthritis and Rheumatism2013402
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected miceScience Translational Medicine2013393
Human Health Risk Assessment (HHRA) for environmental development and transfer of antibiotic resistanceEnvironmental Health Perspectives2013390
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING studyLancet, The2013383
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety updateEuropean Journal of Cancer2013335
Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US populationDigestive Diseases and Sciences2013323
Cognitive relevance of the community structure of the human brain functional coactivation networkProceedings of the National Academy of Sciences of the United States of America2013307
Quantitative multi-parameter mapping of R1, PD(*), MT, and R2(*) at 3T: a multi-center validationFrontiers in Neuroscience2013301
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activityCancer Research2013294
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysisBMC Medicine2013249
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trialsLancet Respiratory Medicine,the2013249
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohortRespiratory Medicine2013243